4//SEC Filing
Kohli Prashant 4
Accession 0001062993-23-014994
CIK 0001444192other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:26 PM ET
Size
5.2 KB
Accession
0001062993-23-014994
Insider Transaction Report
Form 4
Kohli Prashant
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-07-14+208,334→ 208,334 totalExercise: $2.64Exp: 2033-07-14→ Class A Common Shares (208,334 underlying)
Footnotes (1)
- [F1]Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.
Issuer
Acasti Pharma Inc.
CIK 0001444192
Entity typeother
Related Parties
1- filerCIK 0001946739
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:26 PM ET
- Size
- 5.2 KB